What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments

Published:2017-06-07 Issue:8 Volume:28 Page:709-715
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Fairchild Angelyn O.¹,Reed Shelby D.¹²,Johnson F. Reed¹²,Anglin Greg³,Wolka Anne M.⁴,Noel Rebecca A.⁴

Affiliation:

1. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA;

2. Department of Medicine, Duke University School of Medicine, Durham, NC, USA;

3. Eli Lilly Canada, Toronto, Ontario, Canada;

4. Eli Lilly and Company, Indianapolis, IN, USA

Funder

Eli Lilly and Company

Duke University

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2017.1329499

Reference19 articles.

1. Psoriasis prevalence among adults in the United States

2. The Psychosocial Burden of Psoriasis

3. Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course

4. Definition of treatment goals for moderate to severe psoriasis: a European consensus

5. Treatment goals for psoriasis: Should PASI 90 become the standard of care?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE Trial;Acta Dermato-Venereologica;2024-09-05

2. A discrete choice experiment on oral and injection treatment preferences among moderate‐to‐severe psoriasis patients in Japan;The Journal of Dermatology;2023-02-20

3. Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions;MDM Policy & Practice;2023-01

4. The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review;Archives of Dermatological Research;2022-11-06

5. Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting;Patient Preference and Adherence;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3